What problem does this paper attempt to address?

The problem that this paper attempts to solve is the challenges faced in the research and treatment of Alzheimer's disease (AD), especially how to promote the understanding of the pathological mechanism of AD and develop new treatment methods through stem cell technology. Specifically, the paper focuses on the following aspects: 1. **Understanding the complex pathological mechanism of AD**: Current treatments for AD mainly focus on relieving symptoms and slowing down the disease progression, but lack a cure method, mainly because of the limited understanding of the pathogenesis of AD. The paper explores how to use stem cell technology to simulate the pathological process of AD, including issues such as Aβ (amyloid - β) deposition, abnormal tau protein phosphorylation, risk genes, immune system disorders, and incorrect communication between glial cells and neurons. 2. **Establishing more accurate disease models**: Traditional animal models have limitations in studying AD, for example, they cannot fully simulate the complexity and diversity of the human brain. Stem cell technology, especially induced pluripotent stem cells (iPSCs), can generate cell types consistent with the patient's genetic background, thereby better simulating the pathological characteristics of AD. These models can be used not only for studying the molecular mechanism of the disease, but also for drug screening and personalized medicine. 3. **Developing new treatment methods**: Stem cell technology provides new possibilities for the treatment of AD. By transplanting stem cells or their derived cells (such as neurons, glial cells, etc.), damaged neurons can be replaced, neurotrophic support can be provided, and the inflammatory response can be alleviated through immunomodulation. In addition, exosomes derived from stem cells are also considered as a potential treatment method. 4. **Evaluating the effectiveness of existing therapies**: Although monoclonal antibodies against Aβ and tau proteins and other drugs are undergoing clinical trials, most trials have not achieved the desired results and have even been terminated due to serious side effects. The paper discusses the potential advantages of stem cell technology in evaluating the effectiveness of these therapies, especially in the early detection of drug side effects and efficacy. In summary, this paper aims to promote the progress of AD research through stem cell technology, especially in the application of disease modeling, drug screening and cell therapy, in order to find more effective diagnostic and treatment methods.

Promoting Alzheimer's disease research and therapy with stem cell technology